HR 6092 · 116th Congress · Armed Forces and National Security
Veteran’s Prostate Cancer Treatment and Research Act
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.(2020-09-23)
Plain Language Summary
[AI summary unavailable — showing source text]
Veteran's Prostate Cancer Treatment and Research Act This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer. Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment. The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually. Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary dise…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 6092, Veteran’s Prostate Cancer Treatment and Research Act
Nov 24, 2020As ordered reported by the House Committee on Veterans’ Affairs on September 23, 2020
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (3)
1 Democrat2 Republicans